Research Article

Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010

Figure 3

(a) Number of infections in the patients for whom a biological disease-modifying antirheumatic drug (bDMARD) was initiated each year. Open bars: the number of deaths in each year due to infections. Closed bars: the total number of infections for each year. (b) Cumulative incidence of hospitalized infections during the 3-year follow up, according to bDMARD.
(a)
(b)